Patents Assigned to CNG BIO CO., LTD.
  • 4-METHOXY-2-PHENETHYL ISOINDOLINE-1-ONE DERIVATIVE AND COMPOSITION FOR TREATING NEUROLOGICAL DISEASES, COMPRISING SAME
    Publication number: 20230365501
    Abstract: The present invention relates to: a novel 4-methoxy-2-phenethyl isoindolin-1-one derivative compound having the ability to promote the increase of nerve growth factor, the ability to promote the growth of nerve cells, and antineuritic activity; and a composition for preventing, improving and treating neurological diseases, comprising the same.
    Type: Application
    Filed: September 17, 2021
    Publication date: November 16, 2023
    Applicants: CNG BIO CO., LTD., CHUNGBUK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION, GACHON UNIVERSITY OF INDUSTRY-ACADEMIC COOPERATION FOUNDATION
    Inventors: Jaekyung JUNG, Mi Kyeong LEE, Dae Hee LEE, Jae Kang LEE, Sun Yeou KIM, Da Hye YOON, Seong Min HONG
  • 6-METHOXY-2-PHENETHYL ISOINDOLINE-1-ONE DERIVATIVE AND COMPOSITION FOR TREATING NEUROLOGICAL DISORDERS, COMPRISING SAME
    Publication number: 20230331672
    Abstract: The present invention relates to: a novel 6-methoxy-2-phenethyl isoindolin-1-one derivative compound having the ability to promote the increase of nerve growth factor, the ability to promote the growth of nerve cells, and antineuritic activity; and a composition for preventing, improving and treating neurological diseases, comprising the same.
    Type: Application
    Filed: September 17, 2021
    Publication date: October 19, 2023
    Applicants: CNG BIO CO., LTD., CHUNGBUK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION, GACHON UNIVERSITY OF INDUSTRY-ACADEMIC COOPERATION FOUNDATION
    Inventors: Jaekyung JUNG, Mi Kyeong LEE, Dae Hee LEE, Jae Kang LEE, Sun Yeou KIM, Da Hye YOON, Seong Min HONG
  • A Process For Preparing Isoindolinone Derivative, Novel Intermediates Used For The Process, And A Process For Preparing The Intermediates
    Publication number: 20230042112
    Abstract: The present invention relates to a process for preparing an isoindolinone derivative represented by Formula 1, novel intermediates used for the process and a process for preparing the intermediates.
    Type: Application
    Filed: December 3, 2020
    Publication date: February 9, 2023
    Applicants: Chungbuk National University Industry-Academic Coopertion Foundation, CNG Bio Co., Ltd.
    Inventors: Jae-kyung Jung, Mi Kyeong Lee, Vishwanath Manjunatha, Dae-Hee Lee, Jae-Kang Lee
  • Probiotics composition containing hericium erinaceus
    Patent number: 11229672
    Abstract: The present invention relates to a probiotics composition containing: lactic acid bacteria powder comprising lactic acid bacteria selected from the group consisting of Bifidobacterium lactis, Bifidobacterium longum, Lactobacillus acidophilus, Lactobacillus plantarum, and Lactobacillus rhamnosus; a mushroom extract; and a fructooligosaccharide.
    Type: Grant
    Filed: February 16, 2017
    Date of Patent: January 25, 2022
    Assignees: CNG BIO CO., LTD.
    Inventors: Dae Hee Lee, Jae Kang Lee